Merck KGaA has agreed to sell its 21.8 percent stake in Schering to Bayer, clearing the way for Bayer's takeover. Article (WSJ sub. req.)
Deal-Making Insights for the Life Sciences Industry
Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.